2m 2m 2m 2m 2m 2m 2m
TENAX THERAPEUT (TENX)
NASDAQ
$14.06+$0.36 (+2.60%)
Price as of Aug 03, 2026 10:20 AM EDT- $363.4MMarket Cap
- 120.26%1-Year Change
- BiotechnologyIndustry
TENAX THERAPEUT (TENX)
$14.06+$0.36 (+2.60%)
TENX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.70 | ||
Change | -$1.40 (-9.27%) | ||
Open | $15.04 | ||
High | $15.52 | ||
Low | $13.65 | ||
Previous Close | $15.10 | ||
Volume | 1,784,928 | ||
30-Day Average Volume | 1,449,808 | ||
1-Week Change | -5.71% | ||
1-Month Change | -5.84% | ||
1-Year Change | 120.26% | ||
3-Year Change | -45.65% | ||
5-Year Change | -99.51% | ||
Fundamentals | |||
Shares Outstanding | 26.5M | ||
Total Assets | $121.7M | ||
Market Cap | $363.4M | ||
Enterprise Value | $245.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$17.8M | ||
Free Cash Flow | -$14.2M | ||
EBIT | -$17.8M | ||
EBITDA | -$17.8M | ||
Net Working Capital | $113.6M | ||
EPS | -$0.35 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -39 | ||
PEG | N/A | ||
Price/Free Cash Flow | -26 | ||
Price/Operating Cash Flow | -26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 80 | ||
Last Split Date | 01/03/2024 | ||
Earnings & Revenue